Authorized Only

Authorized clients may view prices or make orders.
» Login

New customers apply today by
» Requesting an Account

And one of our team members will review your request and contact you soon!

Contact us


HOSPITEX DIAGNOSTICS is an international engineering, manufacturing and trading company based in Italy since 1993. As a supplier of advanced, reliable and affordable diagnostic equipment, it has gained global recognition for its high quality laboratory solutions including instruments, reagents and consumables, suitable for human and veterinary medicine. A team of quality control managers monitor every step of the production process, ensuring accurate development and realization of the final product. Our company standards allow us to fulfill customer requirements by offering innovative technology, convenience, cost effectiveness and flexibility.


Mission & Strategy

Our mission is to make diagnostics instruments that help to detect diseases.
Our strategy is to create value for all our stakeholders by accelerating the flow of innovative, new cutting-edge equipments and testing kits that provide improved outcomes for laboratories throughout the world.
Most of the products we sell today were discovered or developed by our own scientists and our success depends to great extent on our ability to continue to discover, develop and bring to market innovative new diagnostic equipments.
We manufacture and distribute our products through facilities in Italy and our products are sold in approximately 40 countries


List of countries where the company or products are currently registered

Egypt, Kuwait, Iran, Korea, Vietnam, Philippines, Mongolia, China, Indonesia, Russia, Uzbekistan, Ukraina and Georgia.

Near Term Goals

Operating effectively and acclerating our growth engines During the ongoing global financial crisis, Hospitex was able to sustain growth on its most profitable products during the last five years. We made continuous progress containing costs, even as we sustained our subsutantial investment in R&D.

Medium Term Goals

Pursuing business development and focusing on HPV and related diseases
Our strategy for the medium term includes continued use of business development to help bolster revenues. We are intensely focused on HPV virus and other viruses in the same family. We believe that this family of viruses offers significant business potential as well as leveraging current existing capabilities. Hospitex is currently working with several other companies to jointly develop products for our proprietary platforms. We believe multi-lateral approaches are necessary, especially in R&D. We believe that ultimately, the overall value for all stakeholders is significantly increased when projects are managed together. Hospitex and its partners are focusing on synergies brought on by joint projects. As SMEs, we lack scale- we are directly addressing this shortcoming by amplifying and concentrating on areas where we all can benefit from. Furthermore, by combining our strengths, Hospitex and its partners can leverage greater returns from investments.

Long Term Goals

Reenergizing the pipeline and reinvent R&D
Ultimately, the future of our company depends on bringing to laboratories innovative diagnostic solutions- both from our labs and outside of our walls- and thus driving long term growth. Indeed, we are confident of our growth potential represented by our product pipeline.

Products: HOSPITEX DIAGNOSTICS  manufactures  a  large  range of equipment, accessories, consumables and reagents for medical laboratories. Various types of automatic and semi-automatic analyzers are available to fulfill the daily needs of every diagnostic lab, from rural hospitals to reference diagnostic centres, and they are continuously monitored by our specialists for their accurate performances.
Our range of photometers and cell counters, along with accessories, solutions and consumables, meets the small and medium laboratory needs. Most of our products are open systems. Competition: Our diagnostics products compete with products manufactured by many other companies in highly competitive markets throughout the world. Important competitive factors include safety, effectiveness and ease of use; price and demonstrated cost-effectiveness; marketing effectiveness; and research and development of new products and processes. Most new products that we introduce must compete with other products already on the market or products that are later developed by competitors. Manufacturers of counterfeit, non- proprietary diagnostics equipment makers invest far less than we do in R&D and therefore can price their products much lower than our branded products. .
We believe our long-term competitive success depends upon discovering and developing either alone or in collaboration with others or acquiring innovative cost-effective diagnostic technologies that provide improved outcomes to users. IPR There are currrently under patent important technologies in the field of robotics, fluidics, mechanical and optical solutions applied to diagnostics. HOSPITEX is costantly cooperating with several universities and research centers. R&D is the central focus of our company. R&D is ultimately driven by market demand. Since 2003, Hospitex spent approximately 20% of its sales on R&D.
This figure is quite high in our industry; 8% is the industry average and almost all of our competitors spend under 12%. Hospitex focuses on R&D because we view R&D as our biggest competitive advantage against our competitors. R&D reinforces our core mission; bringing to market the latest, most cost-effective diagnostic equipments. One of the best example of our R&D process is our NANO-MUBIOP project. NANO-MUBIOP patent. WO 2009/040652 : High sensitivity nanotechnology-based multiplexed bioassay method and device.